Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Hold
1,226,800
0.01% 1079
2026
Q1
$110M Hold
1,226,800
0.02% 981
2025
Q4
$114M Hold
1,226,800
0.02% 942
2025
Q3
$153M Hold
1,226,800
0.02% 736
2025
Q2
$161M Hold
1,226,800
0.03% 648
2025
Q1
$129M Hold
1,226,800
0.02% 766
2024
Q4
$133M Hold
1,226,800
0.02% 732
2024
Q3
$131M Hold
1,226,800
0.03% 600
2024
Q2
$121M Buy
+1,226,800
New +$123M 0.03% 547

Other funds holding ITRI

UBS Group's ITRI Position: Q2 2026 in Review

UBS Group reduced its Itron (ITRI) stake by 6% in Q2 2026, selling an estimated $2.85M and leaving 522,162 shares worth $45.2M. The position accounts for 0.01% of the portfolio, ranked #1850.

UBS Group first reported a position in ITRI in Q4 2014 and has held it in 47 quarters since. The position peaked at $67.7M in Q1 2025. 414 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • UBS Group held 522,162 shares of Itron worth $45.2M as of Q2 2026.
  • UBS Group sold 33,438 Itron shares in Q2 2026, an estimated $2.85M.
  • Itron made up 0.01% of UBS Group's portfolio in Q2 2026, its #1850 holding.
  • UBS Group first reported a position in Itron in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Itron position peaked at $67.7M in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.